Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805)

This study is ongoing, but not recruiting participants.

Sponsor:

Collaborators:

Bristol-Myers Squibb

Gilead Sciences

Information provided by (Responsible Party):

Cynthia L Gay, MD, University of North Carolina, Chapel Hill

ClinicalTrials.gov Identifier:

NCT00924898

First received: June 17, 2009

Last updated: August 31, 2012

Last verified: August 2012

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	December 2014
Estimated Primary Completion Date:	December 2013 (Final data collection date for primary outcome measure)

Publications:

C Gay, A Johnson, S McCoy, J Kuruc, K McGee, L McNeil, M Kerkau, J Sebastian, C Pilcher, D Margolis, P Leone, S Fiscus, G Ferrari, C Hicks, J Eron, The Duke-UNC Acute HIV Infection Consortium. "Efficacy of NNRTI-based antiretroviral therapy initiated during acute HIV infection." XVII International AIDS Conference, 2008 Abstract no. THPE0082.

To Top